EchoLaser SoracteLite TPLA: now on RAI national TV
TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology. Prof. Bove was one of the first users of EchoLaser and is the principal... Leggi tutto
Florida New Healthcare Specialists
Nov 3 2022. Elesta and National Ultrasound, Inc. management participated at the #OpenHouse of a newly remodeled location of #Florida #Healthcare #Specialists in Vero Beach, FL. Dr Hugo H Davila, MD, a board certified #urologists, gave the inaugural talk and did the... Leggi tutto
Focal therapy introduced in Urology Varese: maximum precision in the treatment of prostate cancer
EchoLaser arrives at the Hospital of Circle of Varese. A great success thanks to Dr. Federico Deho’ and Dr. Emanuele Z. for the first treatments of #prostate cancer with the technique of laser thermoablation #microinvasive and #transperineal of #SoracteLite.... Leggi tutto
SoracteLite in UK
Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years. Patients can scan a QR Code and book a free... Leggi tutto
SIU 2022
Elesta is gaining visibility i n the Urology space: we are sponsor of the SIU (Società Italiana di Urologia) national congress in Riccione these days. EchoLaser is a game changer for the outpatient, non surgical treatment of Benign Prostatic Hyperplasia. Leggi tutto
The final meeting on Delphi Consensus on SoracteLite™ TPLA for BPH and Pca was held on 26 September 2022
Expert users of EchoLaser for the treatment of BPH – Benign Prostatic Hyperplasia and for focal therapy of prostatic carcinoma (SoracteLite™ TPLA – Transperineal Laser Ablation) gathered yesterday in Florence to finalize a Delphi Consensus project which was... Leggi tutto
